Annette E. Hay

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

Michael Crump, Sattva S. Neelapu, Umar Farooq et al. · Blood · 2017 · 1.6K citations · Full text

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Michael Crump, John Kuruvilla, Stephen Couban et al. · Journal of Clinical Oncology · 2014 · 454 citations · Full text

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group

Matthew D. Seftel, John Kuruvilla, Tom Kouroukis et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 47 citations

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma

Annette E. Hay, Beate Klimm, Bingshu E. Chen et al. · Annals of Oncology · 2013 · 46 citations

Lymphoid Neoplasia, Combined Modality Therapy, Medicine +5

Estimation of Drug Cost Avoidance and Pathology Cost Avoidance through Participation in NCIC Clinical Trials Group Phase III Clinical Trials in Canada

Patricia A. Tang, Annette E. Hay, Chris J. O’Callaghan et al. · Current Oncology · 2016 · 44 citations · Full text